Methods for treating urinary incontinence in mammals
AssigneeMicro Therapeutics, Inc.
InventorsGeorge Wallace, Richard J. Greff
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for treating urinary incontinence in a mammal wherein a composition comprising a biocompatible polymer, a biocompatible solvent, and a contrast agent is delivered to the periurethral tissue of the mammal.
Claims20
A method for treating urinary incontinence in a mammal, which method comprises delivering a composition comprising a biocompatible polymer, a biocompatible solvent, and a contrast agent to the periurethral tissue of the mammal
- wherein said delivery is conducted under conditions such that a polymer precipitate forms in situ in the periurethral tissue thereby reducing urinary incontinence in the mammal.
A method for the delivery of a composition comprising a biocompatible polymer, a biocompatible solvent, and a water insoluble contrast agent to the periurethral tissue of the mammal which tissue already has deposited therein with an initial amount of this composition which method comprises
- visualizing the position of the deposited composition in the periurethral tissue
- delivering a composition comprising a biocompatible polymer, a biocompatible solvent, and a contrast agent to the periurethral tissue of the mammal containing said deposited composition
- wherein said delivery is conducted under conditions such that additional polymer precipitate forms in situ in the periurethral tissue thereby further reducing urinary incontinence in the mammal.
A kit of parts comprising:
- a first member which is an embolic composition comprising a biocompatible polymer, a biocompatible solvent and a contrast agent;
- and
- a second member which is a needle selected from the group consisting of a puncture needle and spinal needle.
A method for treating urinary incontinence in a mammal, which method comprises delivering a composition comprising a biocompatible polymer and a biocompatible solvent to the periurethral tissue of the mammal
- wherein said delivery is conducted under conditions such that a polymer precipitate forms in situ in the periurethral tissue thereby reducing urinary incontinence in the mammal.
Dependencies are inferred from the claim text.